Correction: A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries.
Access
Cardiovascular disease
Essential Medicines
Polypill
Secondary Prevention
Journal
Global heart
ISSN: 2211-8179
Titre abrégé: Glob Heart
Pays: England
ID NLM: 101584391
Informations de publication
Date de publication:
2024
2024
Historique:
received:
07
08
2024
accepted:
07
08
2024
medline:
19
8
2024
pubmed:
19
8
2024
entrez:
19
8
2024
Statut:
epublish
Résumé
[This corrects the article DOI: 10.5334/gh.1335.].
Identifiants
pubmed: 39157209
doi: 10.5334/gh.1350
pmc: PMC11328679
doi:
Types de publication
Published Erratum
Langues
eng
Sous-ensembles de citation
IM
Pagination
64Commentaires et corrections
Type : ErratumFor
Informations de copyright
Copyright: © 2024 The Author(s).
Déclaration de conflit d'intérêts
MDH has received travel support from the World Heart Federation. MDH has an appointment at The George Institute for Global Health, which has a patent, license, and has received investment funding with intent to commercialize fixed-dose combination therapy through its social enterprise business, George Medicines. MDH has pending patents for heart failure polypills. Other authors have no competing interests to declare.